Keyphrases
Genotype
100%
Kindred
100%
Periodic Paralysis
100%
Hypokalemic Periodic Paralysis
80%
Paramyotonia Congenita
80%
Age of Onset
40%
Clinical Data
40%
Coding Region
40%
Myotonia
40%
Muscle Biopsy
40%
Clinical Features
20%
Potassium
20%
New mutation
20%
Old Age
20%
Acetazolamide
20%
Potassium Channel
20%
Clinical Phenotype
20%
Serum Potassium
20%
Clinical Presentation
20%
Electrophysiological Study
20%
Response to Treatment
20%
Rare Disorders
20%
Onset Frequency
20%
Calcium Channel
20%
Proximal Weakness
20%
Sodium Channel
20%
Sodium-to-potassium Ratio
20%
Ion Channel Genes
20%
Attack Duration
20%
CACNA1S
20%
KCNE3
20%
KCNJ2 Gene
20%
SCN4A Gene
20%
Vacuolar Myopathy
20%
Medicine and Dentistry
Thomsen Disease
100%
Periodic Paralysis
75%
Diseases
75%
Onset Age
50%
Weakness
50%
Muscle Biopsy
50%
Myotonia
50%
Hypokalemic Periodic Paralysis
50%
Clinical Feature
25%
Disease
25%
Potassium Channel
25%
Calcium Channel
25%
Ion Channel
25%
Orphan Disorder
25%
Sodium Channel
25%
Myopathy
25%
Acetazolamide
25%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Paramyotonia congenita
100%
Periodic Paralysis
75%
Coding Region
50%
Hyperkalemic Periodic Paralysis
50%
Hypokalemic Periodic Paralysis
50%
Potassium Channel
25%
Calcium Channel
25%
Potassium Blood Level
25%
Sodium Channel
25%
KCNE3
25%
Muscle Level
25%
Ion Channel
25%
Acetazolamide
25%
Neuroscience
Paramyotonia congenita
100%
Periodic Paralysis
75%
Coding Region
50%
Hyperkalemic Periodic Paralysis
50%
Hypokalemic Periodic Paralysis
50%
Calcium Channel
25%
Potassium Channel
25%
Ion Channel
25%
Sodium Channel
25%
Muscle Disorder
25%
Acetazolamide
25%